| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.08. | OneMedNet schließt Datenvertrag für KI-gestützte Medikamentenentwicklung | - | Investing.com Deutsch | ||
| 31.08. | OneMedNet secures AI drug development data agreement | 1 | Investing.com | ||
| 31.08. | OneMedNet Corporation: OneMedNet's iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company | 1 | GlobeNewswire (USA) | ||
| 29.07. | OneMedNet Stock Rallies 33% After Hours: Here's Why | 2 | Benzinga.com | ||
| 28.07. | OneMedNet Corporation: OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development | 1 | GlobeNewswire (USA) | ||
| ONEMEDNET Aktie jetzt für 0€ handeln | |||||
| 24.07. | OneMedNet Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | OneMedNet Corp - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 01.07. | OneMedNet Corp - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 01.07. | OneMedNet Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | OneMedNet secures over $3M in bookings YTD, beating all of 2025 | 2 | Seeking Alpha | ||
| 10.06. | OneMedNet Corporation: OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025 | 1 | GlobeNewswire (USA) | ||
| 03.06. | OneMedNet Corporation: OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network | 1 | GlobeNewswire (USA) | ||
| 20.04. | OneMedNet Corp - 8-K, Current Report | - | SEC Filings | ||
| 06.04. | OneMedNet reports FY results | 1 | Seeking Alpha | ||
| 06.04. | OneMedNet meldet Umsatzwachstum von 329 % und reduziert Verbindlichkeiten um 74 % | 2 | Investing.com Deutsch | ||
| 06.04. | OneMedNet Corporation: OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data | 421 | GlobeNewswire (Europe) | MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-Driven... ► Artikel lesen | |
| 01.04. | Inka Health partners with OneMedNet for oncology data access | 27 | Investing.com | ||
| 01.04. | OneMedNet Corporation: OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI | 348 | GlobeNewswire (Europe) | MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready... ► Artikel lesen | |
| 18.03. | OneMedNet Corporation: OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights | 770 | GlobeNewswire (Europe) | MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready... ► Artikel lesen | |
| 12.02. | OneMedNet Corporation: OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition | 662 | GlobeNewswire (Europe) | MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), today announced... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| HEALWELL AI | 0,490 | -1,90 % | HEALWELL AI: HEALWELL's DARWEN to Power AI-Driven Clinical Trial Matching for WELLTRUST, a Network of Over 100,000 Consented Patients | HEALWELL's DARWEN AI platform is used to connect WELLTRUST patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching... ► Artikel lesen | |
| SPINEWAY | 0,115 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,909 | -7,91 % | Tempest Therapeutics: Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update | Executed a development collaboration with Senlang Biotechnology to advance certain in vivo CAR-T product candidates, including TPST-4003, a CD7-targeted next-generation in vivo CAR-T, with first patient... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,99 | -0,91 % | Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth? | ||
| FRESENIUS | 43,860 | -1,85 % | Fresenius-Aktie +5%: Geht da noch mehr? | Zuletzt ging es mit der Fresenius-Aktie leicht bergab, doch am Dienstagvormittag setzt sich der Gesundheitskonzern mit einem Kursgewinn von +5% an die Spitze im DAX. Was steckt hinter dem Kursplus und... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,690 | -0,79 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Die Innovationsdynamik bleibe hoch, schrieb Julien... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,540 | -0,64 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,030 | -3,19 % | Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding Potential Securities Law Violations | ||
| LIFESTANCE HEALTH GROUP | 12,595 | -1,56 % | LifeStance prices 22.3 million share secondary offering at $12.35 | ||
| GENEDX | 86,48 | +0,71 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| HEARTFLOW | 46,720 | -2,12 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BILLIONTOONE | 99,05 | -0,01 % | Canaccord initiates BillionToOne stock coverage with buy rating | ||
| AVEANNA HEALTHCARE | 14,030 | +2,71 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,780 | -1,28 % | 411 Milliarden US-Dollar Schaden pro Jahr: Warum Augengesundheit für Carl Zeiss Meditec, Alcon & Co. zum Technologiemarkt wird - und wo Rise Nano Optics ins Spiel kommt |